Literature DB >> 22605598

Neurosurgical management of L-asparaginase induced haemorrhagic stroke.

Elisha Ogbodo1, Chandrasekaran Kaliaperumal, Michael O'Sullivan.   

Abstract

The authors describe a case of L-asparaginase induced intracranial thrombosis and subsequent haemorrhage in a newly diagnosed 30-year-old man with acute lymphoblastic leukaemia who was successfully managed by surgical intervention. At presentation, he had a Glasgow Coma Score of 7/15, was aphasic and had dense right hemiplegia. Neuroimaging revealed an acute anterior left middle cerebral artery infarct with parenchymal haemorrhagic conversion, mass effect and subfalcine herniation. He subsequently underwent left frontal craniotomy and evacuation of large frontal haematoma and decompressive craniectomy for cerebral oedema. Six months postoperatively he underwent titanium cranioplasty. He had made good clinical recovery and is currently mobilising independently with mild occasional episodes of expressive dysphasia, difficulty with fine motor movement on the right side, and has remained seizure free. This is the first documented case of L-asparaginase induced haemorrhagic stroke managed by neurosurgical intervention. The authors emphasise the possible role of surgery in managing chemotherapy induced intracranial complications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22605598      PMCID: PMC3316831          DOI: 10.1136/bcr.11.2011.5240

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  The effect of L-asparaginase of plasma coagulation factors in acute lymphoblastic leukemia.

Authors:  N K Ramsay; P F Coccia; W Krivit; M E Nesbit; J R Edson
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

2.  Dural sinus thrombosis in leukemia.

Authors:  D J Ganick; W C Robertson; C Viseskul; M S Lubinsky
Journal:  Am J Dis Child       Date:  1978-10

3.  Intracranial bleeding during therapy with L-asparaginase in childhood acute lymphocytic leukemia.

Authors:  C Urban; W D Sager
Journal:  Eur J Pediatr       Date:  1981-11       Impact factor: 3.183

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  Strokes and the neurotoxicity of l-asparaginase.

Authors:  L White; L S Fishman; N A Shore
Journal:  J Pediatr       Date:  1981-07       Impact factor: 4.406

6.  Stroke due to treatment with L-asparaginase in an adult.

Authors:  G S Lederman
Journal:  N Engl J Med       Date:  1982-12-23       Impact factor: 91.245

Review 7.  Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature.

Authors:  N I Weijl; M F Rutten; A H Zwinderman; H J Keizer; M A Nooy; F R Rosendaal; F J Cleton; S Osanto
Journal:  J Clin Oncol       Date:  2000-05       Impact factor: 44.544

8.  Intracranial hemorrhage and focal seizures secondary to use of L-asparaginase during induction therapy of acute lymphocytic leukemia.

Authors:  M S Cairo; K Lazarus; R L Gilmore; R L Baehner
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

9.  Thrombotic and hemorrhagic strokes complicating early therapy for childhood acute lymphoblastic leukemia.

Authors:  J R Priest; N K Ramsay; R E Latchaw; L A Lockman; D K Hasegawa; T D Coates; P F Coccia; J R Edson; M E Nesbit; W Krivit
Journal:  Cancer       Date:  1980-10-01       Impact factor: 6.860

10.  The influence of L-asparaginase therapy on the fibrinolytic system.

Authors:  E Vellenga; C Kluft; N H Mulder; G Wijngaards; H O Nieweg
Journal:  Br J Haematol       Date:  1984-06       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.